[
  {
    "ts": null,
    "headline": "McKesson Corporation (MCK): A Bull Case Theory",
    "summary": "We came across a bullish thesis on McKesson Corporation on The Buyside Guy’s Substack. In this article, we will summarize the bulls’ thesis on MCK. McKesson Corporation’s share was trading at $710.94 as of August 4th. MCK’s trailing and forward P/E were 27.17 and 18.69, respectively according to Yahoo Finance. McKesson (MCK) is one of the largest […]",
    "url": "https://finnhub.io/api/news?id=93447ab12bc6b9e068c76bc74fe00f89a1f7217afc57ff77bcd1c5eeef531878",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754416660,
      "headline": "McKesson Corporation (MCK): A Bull Case Theory",
      "id": 136215439,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "We came across a bullish thesis on McKesson Corporation on The Buyside Guy’s Substack. In this article, we will summarize the bulls’ thesis on MCK. McKesson Corporation’s share was trading at $710.94 as of August 4th. MCK’s trailing and forward P/E were 27.17 and 18.69, respectively according to Yahoo Finance. McKesson (MCK) is one of the largest […]",
      "url": "https://finnhub.io/api/news?id=93447ab12bc6b9e068c76bc74fe00f89a1f7217afc57ff77bcd1c5eeef531878"
    }
  },
  {
    "ts": null,
    "headline": "Can Sustained Product Demand Drive BDX Stock Before Q3 Earnings?",
    "summary": "BD's third-quarter fiscal 2025 results are likely to benefit from product launches across Medical and Interventional segments, which drive strong revenue potential.",
    "url": "https://finnhub.io/api/news?id=b38b302b1f455548746465b927be3bac2de3c546c23522a5004604e553fb50dc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754410560,
      "headline": "Can Sustained Product Demand Drive BDX Stock Before Q3 Earnings?",
      "id": 136215099,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "BD's third-quarter fiscal 2025 results are likely to benefit from product launches across Medical and Interventional segments, which drive strong revenue potential.",
      "url": "https://finnhub.io/api/news?id=b38b302b1f455548746465b927be3bac2de3c546c23522a5004604e553fb50dc"
    }
  },
  {
    "ts": null,
    "headline": "Can Solventum Sustain Growth Amid Tariff Headwinds in Q2 Earnings?",
    "summary": "SOLV's Q2 earnings are likely to test whether solid segment growth can offset tariff and ERP-related pressures.",
    "url": "https://finnhub.io/api/news?id=d64ee3fe8bf9548547dce1244c10233d45eaf942581ec7425dbd03052f1d2162",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754408520,
      "headline": "Can Solventum Sustain Growth Amid Tariff Headwinds in Q2 Earnings?",
      "id": 136215100,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "SOLV's Q2 earnings are likely to test whether solid segment growth can offset tariff and ERP-related pressures.",
      "url": "https://finnhub.io/api/news?id=d64ee3fe8bf9548547dce1244c10233d45eaf942581ec7425dbd03052f1d2162"
    }
  },
  {
    "ts": null,
    "headline": "Henry Schein Stock Falls on Q2 Earnings Miss, Revenues Top",
    "summary": "HSIC slides after Q2 EPS misses estimates by 6.8%. Revenues beat with 3.2% growth and strength across key segments.",
    "url": "https://finnhub.io/api/news?id=39657e6b013d99836649a356c872d8f4c8e06da49694853c310459cfd6cdf6ed",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754399100,
      "headline": "Henry Schein Stock Falls on Q2 Earnings Miss, Revenues Top",
      "id": 136215009,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "HSIC slides after Q2 EPS misses estimates by 6.8%. Revenues beat with 3.2% growth and strength across key segments.",
      "url": "https://finnhub.io/api/news?id=39657e6b013d99836649a356c872d8f4c8e06da49694853c310459cfd6cdf6ed"
    }
  },
  {
    "ts": null,
    "headline": "Will GLP-1 Demand Drive MCK's Top Line This Earnings Season?",
    "summary": "MCK's Q1 results are expected to reflect strong prescription volume growth from GLP-1 demand, but lower margins may weigh on profitability.",
    "url": "https://finnhub.io/api/news?id=eca767c58e58b678018ed7a87f37944c48ddcb8e31926265ba0b712b4643c45e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754393760,
      "headline": "Will GLP-1 Demand Drive MCK's Top Line This Earnings Season?",
      "id": 136212498,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CAH",
      "source": "Yahoo",
      "summary": "MCK's Q1 results are expected to reflect strong prescription volume growth from GLP-1 demand, but lower margins may weigh on profitability.",
      "url": "https://finnhub.io/api/news?id=eca767c58e58b678018ed7a87f37944c48ddcb8e31926265ba0b712b4643c45e"
    }
  }
]